TUMOR-ASSOCIATED HYPERINSULINISM (TUMOR HI)

Clinical trials for TUMOR-ASSOCIATED HYPERINSULINISM (TUMOR HI) explained in plain language.

Never miss a new study

Get alerted when new TUMOR-ASSOCIATED HYPERINSULINISM (TUMOR HI) trials appear

Sign up with your email to follow new studies for TUMOR-ASSOCIATED HYPERINSULINISM (TUMOR HI), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Lifeline offered for patients with dangerous Tumor-Related low blood sugar

Disease control AVAILABLE

This program provides access to an investigational drug called ersodetug for people with tumor-associated hyperinsulinism who suffer from severe, uncontrolled low blood sugar and cannot participate in regular clinical trials. It is designed for patients whose condition is not ade…

Matched conditions: TUMOR-ASSOCIATED HYPERINSULINISM (TUMOR HI)

Sponsor: Rezolute • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

TUMOR-ASSOCIATED HYPERINSULINISM (TUMOR HI)

Get alerted when new TUMOR-ASSOCIATED HYPERINSULINISM (TUMOR HI) trials appear

Lifeline offered for patients with dangerous Tumor-Related low blood sugar